C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/19/2002	WO2002061136A3 ISOLATED BOVINE IgG PROTEIN AND ITS USE AS AN ANTIMICROBIAL AGENT
12/19/2002	WO2002048334A3 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2001083739A3 Human pellino polypeptides
12/19/2002	WO2001082788A9 Compounds and methods for the treatment and prevention of bacterial infection
12/19/2002	WO2001079481A8 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001075087A3 Subtilisin variants
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194638 Vector for genetically modifying non-human animals
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020193575 Fusion protein for use in the treatment of allergies
12/19/2002	US20020193574 High affinity humanized anti-tag-72 monoclonalantibodies
12/19/2002	US20020193573 Methods for making antibody fragments and compositions resulting therefrom
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193569 Immunoconjugate for use in the treatment of cancer
12/19/2002	US20020193564 Polypeptide for use in the treatment of muscular, huntington's and alzhemiers's diseases
12/19/2002	US20020193326 Methods of inhibiting proliferative diseases
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193304 Anti-HIV agents
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020192820 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/19/2002	US20020192814 Colloidal metal compositions and methods
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192792 Laccase mutants
12/19/2002	US20020192787 Polypeptide for use in the diagnosis, treatment, and prevention of cancer and developmental defects
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192764 Anti-paratopic antibody as an immunogen
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192751 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of sepsis and inflammatory defects
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192724 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192672 Cell culture for use in the detection of ehrlichia infections
12/19/2002	US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192276 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
12/19/2002	US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192227 Vaccines against cancer and infectious diseases
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192221 Method for treating tumor using a combination of energy and antibody conjugated toxin
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192218 Oncoprotein protein kinase
12/19/2002	US20020192215 Novel uses of mammalian OX2 protein and related reagents
12/19/2002	US20020192213 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/19/2002	US20020192212 Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine
12/19/2002	US20020192211 Method of treating tumor cells by inhibiting growth factor receptor function
12/19/2002	US20020192210 Dendritic cell-specific antibodies
12/19/2002	US20020192209 Methods and compositions for inhibiting neoplastic cell growth
12/19/2002	US20020192208 Novel osteopontin derived chemotactic peptides and methods of use
12/19/2002	US20020192205 Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192190 Induction of immunological tolerance
12/19/2002	US20020192160 Novel human tumor suppressor gene
12/19/2002	DE10127712A1 Use of immunoglobulin M for treatment and prevention of systemic lupus erythematosus, administered subcutaneously or intramuscularly
12/19/2002	CA2488850A1 Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer
12/19/2002	CA2450663A1 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2450131A1 Respiratory syncytial virus
12/19/2002	CA2450113A1 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2449259A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	CA2447791A1 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	CA2445898A1 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/19/2002	CA2445605A1 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	CA2418808A1 Human-type anti-blood coagulation factor viii antibody
12/18/2002	EP1267167A1 Method for identifying HCV entry factors
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP1266666A2 Fibrin sealant compositions and method for utilizing same
12/18/2002	EP1266663A1 Eosinophil-specific apoptosis inducer
12/18/2002	EP1266662A2 Synthetic peptide vaccines for dental caries
12/18/2002	EP1266221A1 Mage antigenic peptides which bind hla-b35 and hla-b44
12/18/2002	EP1266026A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta
12/18/2002	EP1266025A1 Protein scaffolds for antibody mimics and other binding proteins
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex

1 ... 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 ... 1494